Inflammatory bowel disease (IBD) impacts 1.6 million people in the U.S. — and a new artificial intelligence -generated drug could help alleviate symptoms. NEW AI-GENERATED COVID DRUG ENTERS PHASE I CLINICAL TRIALS: ‘EFFECTIVE AGAINST ALL VARIANTS’Many current drugs for IBD are anti-inflammatory and rely on immunosuppression to work. FIRST AI-GENERATED DRUG ENTERS HUMAN CLINICAL TRIALS, TARGETING CHRONIC LUNG DISEASE PATIENTS"You can think of Chemistry42 as a ChatGPT for new molecules," said Zhavoronkov. Inflammatory bowel disease (IBD) impacts 1.6 million people in the U.S., causing symptoms that include diarrhea, abdominal pain, fatigue, weight loss and rectal bleeding. Original article source: AI-designed drug for inflammatory bowel disease enters human clinical trials: 'A significant need'

Source: Fox News January 28, 2024 11:36 UTC